Therapeutic Expertise

Home

Attention: open in a new window.

For over 20 years CPC has provided expert trial management and oversight for more than 75 clinical trials in the cardiovascular area including Peripheral Arterial Disease (PAD), Critical Leg Ischemia (CLI), Hypertension (HTN), Deep Vein Thrombosis (DVT), Coronary Artery Disease (CAD), and Metabolic Syndrome. While maintaining this focus, CPC has expanded into other therapeutic areas including:

Cardiology
Dermatology/Wound Healing
Endocrinology
Geriatric populations
Infectious Disease
Nephrology
Oncology
Ophthamology
Pediatric populations
Phase I trials for healthy and diseased populations
Pulmonary/Respiratory
Stem Cell

CPC provides the full spectrum of clinical trial management services for drugs, devices, biologics, medical foods, diagnostics, observational and outcomes research.

DrHiatt

CPC brings an insider perspective to FDA approval decisions. Dr. William Hiatt, President of CPC, is the immediate past chairman of the FDA Cardiovascular and Renal Drugs Advisory Committee (2003-08) and currently serves FDA as a Special Government Employee Consultant. Additionally Dr. Mori Krantz, Vice President of Community Health Development at CPC, currently serves on the FDA Cardiovascular and Renal Drugs Advisory Committee.